SoftBank Vision Fund Leads $400 Million Series C for Relay Therapeutics

Palo Alto – December 27, 2018 – Cooley advised SoftBank Vision Fund on leading Relay Therapeutics’ $400 million Series C financing. Partners Matthew Bartus, co-chair of Cooley’s global emerging companies practice, and Bradley Libuit led the team advising SoftBank on the investment.

According to Relay, proceeds from this financing are anticipated to be used to accelerate the implementation of its long-term strategy. It will support the expansion of the company’s discovery efforts, advance existing programs into the clinic and bolster its broad platform and diverse team.

Relay is committed to creating medicines that will have a transformative impact on patients by building a unique discovery platform centered on understanding how the conformation of proteins relate to function.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.